Clinical Trials Directory

Trials / Completed

CompletedNCT04079517

Karolinska Interventional Study of Mammograhic Density (Karisma-1)

A Randomized, Open Pilot Study to Investigate the Mammographic Density Reduction on Healthy Women, Within the Karma Cohort, for Two Different Doses of Tamoxifen

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Karolinska Institutet · Academic / Other
Sex
Female
Age
40 Years – 74 Years
Healthy volunteers
Accepted

Summary

A feasibility study, randomising to either 10 or 20 mg of tamoxifen. The primary aim is to identify the time to mammographic density change and piloting the procedures. It is known that a density change is seen after 12 months of 20 mg of tamoxifen, but the clinical experience indicates that an effect of drugs influencing mammographic density could be seen already after a few months. The second aim is to evaluate if there is a density change from 10 mg of tamoxifen equivalent to 20 mg.

Detailed description

The investigators want to conduct a feasibility study including 42 women who will be randomised to either 10 or 20 mg of daily oral tamoxifen. The primary aim of the study is to identify the time to mammographic density change and piloting the procedures. It is known that a density change is seen after 12 months of 20 mg of daily tamoxifen, but the clinical experience indicates that an effect of drugs influencing mammographic density could be seen already after a few months. The second aim of the pilot study is to see if there is a density change from 10 mg of tamoxifen equivalent to 20 mg and if there is a difference in adverse reactions between the two doses. Interim analysis will be performed at 6 months, monitoring both safety and level of mammographic density change.

Conditions

Interventions

TypeNameDescription
DRUGTamoxifenA registered SERM drug, Tamoxifen.

Timeline

Start date
2015-03-01
Primary completion
2016-02-01
Completion
2016-03-01
First posted
2019-09-06
Last updated
2025-02-06
Results posted
2025-02-06

Source: ClinicalTrials.gov record NCT04079517. Inclusion in this directory is not an endorsement.